A Study of Cizutamig for Patients With Ulcerative Colitis
NCT07353450 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2026-01-20
Summary
A Study of Cizutamig for Patients with Ulcerative Colitis
Conditions
- Ulcerative Colitis (UC)
Interventions
- BIOLOGICAL
-
cizutamig
Cizutamig will be dosed according to the protocol
Sponsors & Collaborators
-
Ruijin Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-31
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- China
Study Locations
More Related Trials
-
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
NCT02054533 ·Status: COMPLETED
-
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis
NCT03653026 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)
NCT04700449 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
NCT01164904 ·Status: TERMINATED ·Phase: PHASE1
-
Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative Colitis
NCT06962020 ·Status: RECRUITING
-
Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis
NCT05205603 ·Status: COMPLETED ·Phase: PHASE4
-
IUS Predicts Upadacitinib Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study
NCT06573944 ·Status: RECRUITING
-
COLISURG : Exploratory Analysis of Sexual Function and the Impact of Biotherapies on Postoperative Morbidity.
NCT03504930 ·Status: UNKNOWN
-
A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice
NCT04963725 ·Status: COMPLETED
-
Open-Label Adalimumab for Ulcerative Colitis Patients
NCT00421642 ·Status: COMPLETED ·Phase: PHASE1
-
A Cohort Study Comparing IFX to CS for Moderate to Severe UC
NCT04879966 ·Status: UNKNOWN
-
An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice
NCT05369832 ·Status: TERMINATED ·Phase: PHASE4
-
Faecal Microbiota Transplantation in Ulcerative Colitis
NCT01896635 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
NCT00573794 ·Status: COMPLETED ·Phase: PHASE3
-
Predicting Biologic Therapy Success in Ulcerative Colitis Using Intestinal Ultrasound and Fat Assessment
NCT07126015 ·Status: NOT_YET_RECRUITING
-
Prognosis in UC After First Biological
NCT05530122 ·Status: COMPLETED
-
A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice
NCT03532932 ·Status: COMPLETED
-
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
NCT03398135 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
NCT02914535 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Basiliximab in Moderate to Severe Ulcerative Colitis
NCT00430898 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis
NCT07271069 ·Status: RECRUITING
-
Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants
NCT07350577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Clinical Outcome of Treatment of Ulcerative Colitis in Adult
NCT06143163 ·Status: NOT_YET_RECRUITING
-
Critical State of "Remission-Recurrence" of Ulcerative Colitis
NCT06694883 ·Status: RECRUITING
-
A Multicentered Prospective Cohort Study of Chinese IBD Patients
NCT05386290 ·Status: UNKNOWN